Peter Atadja

Peter Atadja

Chief Tech/Sci/R&D Officer at
CommBio Therapeutics Co., Ltd.
66 year
Health Technology
Consumer Services

Profile

Peter Atadja is currently the Chief Scientific Officer at CommBio Therapeutics Co., Ltd. He previously worked at Novartis Pharmaceuticals Corp.
as the Executive Director & Head-Drug Discovery from 1997 to 2021.
Additionally, he served as an Independent Director at Traws Pharma, Inc. from 2022 to 2024.
Dr. Atadja also held the position of Chief Scientific Officer at K36 Therapeutics, Inc. in the past.
He holds a doctorate degree from the University of Calgary, a graduate degree from The Hebrew University of Jerusalem, and an undergraduate degree from Kwame Nkrumah University of Science & Technology.

Peter Atadja active positions

CompaniesPositionStart
CommBio Therapeutics Co., Ltd.
Chief Tech/Sci/R&D Officer -

Former positions of Peter Atadja

CompaniesPositionEnd
TRAWS PHARMA, INC. Director/Board Member 2024-03-31
Director/Board Member 2020-12-31
Chief Tech/Sci/R&D Officer -
See the detail of Peter Atadja's experience

Training of Peter Atadja

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

89

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

CommBio Therapeutics Co., Ltd.

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!